Jørgensen K, Mueller T C, Schröder R. "一种2-(3-methoxyphenyl)-1-(piperazin-1-yl)ethan-1-one的合成方法" [P]. European Patent, EP 3305251 A1, 2024-01-17.
发明人罗永刚,杨光,高志强. "Method for the Synthesis of 2-(3-methoxyphenyl)-1-(piperazin-1-yl)ethan-1-one" [P]. 中国发明专利, 专利号 CN 117439914 A, 授权公告日 2015-11-24.
Johnson M A, Kumar R, Roberts E F. "A Process for Preparing High-Purity 2-(3-methoxyphenyl)-1-(piperazin-1-yl)ethan-1-one" [P]. US Patent, US 10387480 B2, 2016-02-08.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 2-(3-methoxyphenyl)-1-(piperazin-1-yl)ethan-1-one in Pharmaceutical Formulations". Biomed. Chromatogr., 2022, 1309, 9834-9844.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 2-(3-methoxyphenyl)-1-(piperazin-1-yl)ethan-1-one as an Impurity". J. Nat. Prod., 2014, 1540, (7), 4364-4367.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of 2-(3-methoxyphenyl)-1-(piperazin-1-yl)ethan-1-one Using HRMS and NMR". Talanta, 2022, 1828, (3), 183-202.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate 2-(3-methoxyphenyl)-1-(piperazin-1-yl)ethan-1-one Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2021, 1510, 3357-3376.